From these findings we conclude, that PTX3 not only inhibits CaOx crystal growth, but also abolishes the upregulation of crystal adhesion molecules after CaOx crystal challenge in vitro and in vivo, thereby additionally counteracting the development of nephrocalcinosis and CKD under hyperoxaluric conditions. Here, PTX3 is linked to nephrocalcinosis.